New hope for teens with severe depression: testing a powerful treatment combo
NCT ID NCT07247968
Summary
This study is testing if adding a low dose of the medication esketamine to standard electroconvulsive therapy (ECT) is more effective for treating severe depression in teenagers. Researchers will compare two groups of 110 adolescents each: one receiving esketamine with ECT and one receiving a placebo with ECT. The main goal is to see if the esketamine group has a higher response rate, meaning their depression symptoms are cut in half.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Chongqing Medical University
NOT_YET_RECRUITINGChongqing, China
-
The First Affiliated Hospital of Chongqing Medical University
RECRUITINGChongqing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.